Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 913articles · 365d
- 1+ day agolatest article
- Sep 14, 2025earliest in window
- 95%with images
- 285avg words
- Medical 573
- Business & Industrial 538
- Economy, Business & Finance 451
- Health & Wellness 337
- Health 267
- Finance & Business 254
- Science & Technology 156
- Science & Nature 42
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B
5+ day, 3+ hour ago (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2+ week, 5+ day ago (647+ words) Pharmaceutical Executive...
Focusing on Asset Acquisition Over Building a Single Platform Technology
2+ week, 6+ day ago (199+ words) Pharmaceutical Executive Earlier this year, Pharmaceutical Executive reported on Chinaâs growing prominence in the pharma and biotech spaces During this year, billions of dollars have been committed to licensing commitments with Chinese companies, with many US-based companies making up…...
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
3+ week, 2+ day ago (340+ words) Amplitude Therapeutics enters a collaboration with Eli Lilly to develop trans-amplifying RNA vaccines, while Chai Discovery partners with Bristol Myers Squibb to deploy its AI molecular folding and design models across BMS's antibody discovery portfolio. As of August 21, financial terms…...
Beyond the Segment: How Persona Intelligence Helps Refine HCP Engagement at Scale
1+ mon, 1+ day ago (509+ words) Overcoming the limits of traditional segmentation through a more connected, responsive and effective approach to health care professional engagement. From Dashboards to Decisions: How AI Is Reshaping Pharma Brand Strategy The Questions You Couldn’t Ask in Time: How Agentic AI…...
Your Product Is Ready. Your Launch Strategy Isn't
1+ mon, 3+ day ago (180+ words) Insights into the "differentiation paradox" from a study of 340 drug launches. Addressing Launch Drift to Optimize Product Launches Why Gross-to-Net Internal Controls Should Be a Launch Priority for Specialty Pharma Companies The Questions You Couldn’t Ask in Time: How Agentic…...
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
1+ mon, 3+ day ago (273+ words) Novo Nordisk selects AWS as its preferred AI partner for drug discovery, Innate Pharma partners with Sobi, and Innovent Biologics secures exclusive commercialization rights for Vanflyta in China. A wave of new partnerships is overtaking the pharma sector and reshaping…...
The Significance of FDA???s First Warning Letter for Inappropriate Use of AI
1+ mon, 3+ day ago (191+ words) Krieger Scientific's Joseph Morwald on why unverified AI-generated documentation in pharma is a complex issue with potentially significant consequences. In July of this year, Krieger Scientific issued a release addressing the increase in 303 drug warning letters issued by FDA. In…...
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
1+ mon, 3+ day ago (518+ words) Veeva's president of commercial strategy discusses how agentic AI is surfacing the treatment barriers and HCP insights that traditional call reporting was never built to capture. In the new Agentic Commercial model for life sciences, agentic AI compliantly delivers Commercial…...
Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals
1+ mon, 1+ week ago (585+ words) In today's Pharmaceutical Executive Daily, Pathos AI signs licensing deals with Alphamab Oncology and AstraZeneca while Curium agrees to acquire Lantheus for up to $8 billion, Sandoz agrees to a $450 million settlement with 43 U.S. states over generic drug antitrust claims, and a…...